Cargando…
Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer’s and Parkinson’s Diseases: Insights into Current Medications
Two of the most prevalent neurodegenerative disorders (NDDs), Alzheimer’s disease (AD) and Parkinson’s disease (PD), present significant challenges to healthcare systems worldwide. While the etiologies of AD and PD differ, both diseases share commonalities in synaptic dysfunction, thereby focusing a...
Autores principales: | Gautam, Deepa, Naik, Ulhas P., Naik, Meghna U., Yadav, Santosh K., Chaurasia, Rameshwar Nath, Dash, Debabrata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669830/ https://www.ncbi.nlm.nih.gov/pubmed/38002291 http://dx.doi.org/10.3390/biom13111609 |
Ejemplares similares
-
Glutamate induces synthesis of thrombogenic peptides and extracellular vesicle release from human platelets
por: Gautam, Deepa, et al.
Publicado: (2019) -
Fibrinogen Mitigates Prion-Mediated Platelet Activation and Neuronal Cell Toxicity
por: Gautam, Deepa, et al.
Publicado: (2022) -
Binding of CIB1 to the α(IIb) tail of α(IIb)β(3) is required for FAK recruitment and activation in platelets
por: Naik, Meghna U., et al.
Publicado: (2017) -
Dysregulation of Ambient Glutamate and Glutamate Receptors in Epilepsy: An Astrocytic Perspective
por: Alcoreza, Oscar B., et al.
Publicado: (2021) -
Aspirin resistance and blood biomarkers in predicting ischemic stroke recurrence: An exploratory study
por: Dash, Prerana, et al.
Publicado: (2022)